Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2023 > 06 > 20
Other dates of the month:
- Brookfield Infrastructure and Ontario Teachers’ to Acquire Compass Datacenters from RedBird Capital Partners and Azrieli Group
- CarMax (KMX) to Report Q1 Earnings: What's in the Offing?
- Ghana aims to exempt Afrexim loans from debt restructuring
- TELUS (TU) Invests to Upgrade Network Infrastructure in Montreal
- Power naps can slow down your brain’s aging process—so is it time employers embrace snoozing on the clock?
- Brand New Survey Results on the First State of GovCon Journalism Report
- Spotify plans a more expensive subscription tier - Bloomberg News
- AVANGRID (AGR) Rides on Investments & Expanding Clean Portfolio
- Vans sneakers maker VF taps Logitech's Bracken Darrell as CEO
- McKinsey and McDonald’s advertise their employee turnover to attract top talent. Here’s why you should too
- Iris Energy Announces 9.1 EH/s Expansion Plan and Revitalization of HPC Strategy
- Ready to game? The HyperX Cloud Alpha wired gaming headset is $20 off today
- EU starts debate on economic security with eye on China
- Spotify replaces Meghan with comedian accused of calling Britain racist
- Global Agricultural Adjuvants Market Forecast to 2030: Increasing Demand for Crop Protection Chemicals for Improving the Yield of Crops Drives Growth
- AB InBev’s chief marketing exec calls boycott over its Bud Light beer an ‘important wake-up call’ for brands to be ‘very humble’
- Metro Detroit's 'The Roof Resource' Expands Nationally With First Home-Based Business Franchise Opportunity in the Industry
- ARS Pharmaceuticals Announces PDUFA Date Extension for neffy® (Intranasal (IN) Epinephrine) for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis
- AcuityAds Announces Company Name Change to illumin
- HMNC Brain Health Begins Phase 2 Study for Personalized Treatment of Stress-Axis Related Major Depressive Disorder (MDD)
- Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis
- ITC Accepts Shoals Technologies Group’s Complaint to Investigate Alleged Importation of Infringing Hikam and Voltage Products
- Worksport Ltd. To Apply for ISO 9000 Certification
- Ramon.Space and Foxconn Partner to Launch Revolutionary High-Volume Space Computing Products
- LifeMD Appoints William J. Febbo to its Board of Directors
- aTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod at the World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Conference
- ETF Areas & Stocks to Win on Upbeat May Retail Sales
- Appeal of Delisting Determination
- Aridis Pharmaceuticals' AR-301 Eligible for Consideration under FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD)
- Photoelectric Sensors Market to Reach $2 Billion by 2030 - Exclusive Report by Meticulous Research®
- D-BOX Technologies is Celebrating its 25th Anniversary
- Livento Group (NUGN) BOXO New Projects - "The Lion, the Polygamist, and the Biofuel Scam" and the Game "Medieval"
- Icosavax Initiates Phase 2 Trial of IVX-A12 Against RSV and hMPV in Older Adults
- South Dakota Recognized with a StateScoop 50 Award for Property Tax Modernization
- Kaltura Wins “Overall e-Learning Solution of the Year” in the 5th Annual EdTech Breakthrough Awards Program
- TRACON Pharmaceuticals Announces Positive Results Based on Ongoing Double-Digit Objective Response Rate for Single Agent Envafolimab in the ENVASARC Phase 2 Pivotal Trial
- Initial Results Confirm Widespread Mineralization at Appia's Ionic Clay Project in Goias State, Brazil
- KnowBe4’s Annual Phishing Benchmarking Report Finds Untrained Users Are Biggest Flaw in Organizations’ Cyber Defense Layer
- Magna Terra Provides Update on Recent Exploration Results by Partner Opus One at Noyell Project, Quebec
- LifeQuest Announces Current Commitments for Its Biopipe Sewage Treatment Systems Totaling $2.4 Million.
- Optimum Ventures Ltd. Announces Letter of Intent With Blackwolf Copper and Gold Ltd.
- Nuvectis Pharma Set to Join the Russell 2000® and Russell 3000® Indexes
- PDS Biotech to be Added to Russell 2000® and Russell 3000® Indexes Effective June 26, 2023
- Food-safe microchips could be Canada’s answer to food traceability concerns
- Trio Petroleum Corp Announces Update on Activity Related to its HV-1 Discovery Well
- Spectral Medical Provides Update on Continued Favorable Tigris Clinical Trial Enrollment
- 2023 FinHealth Spend Report Finds Fees and Interest on Non-Mortgage Financial Services Skyrocket 14% to $347 Billion
- ShapeTX Announces the Appointment of Adrian W. Briggs, Ph.D. As Chief Technology Officer
- CFA Institute Celebrates 60 Years of the CFA® Program
- Salus GRC Announces the Addition of Two Industry Veterans